Prenetics Global director Leogrande Hudson Blake exercised Options for 2,000 shares at $0 per share. For investors tracking PRE, the transaction leaves stated holdings of 6,001 shares and 18,003 derivative securities, clarifying the director’s reported ownership following the exercise.
Key Highlights
- The transaction occurred on 4 September 2026 under SEC transaction code M.
- Leogrande Hudson Blake’s reported post-transaction holdings include 6,001 Prenetics Global shares.
- Blake also held 18,003 derivative securities after the transaction.
Prenetics Global Ltd (NASDAQ: PRE) director Leogrande Hudson Blake exercised options for 2,000 shares at $0 per share.
Director’s Post-Transaction Holdings The
option exercise took place on 4 September 2026 under SEC transaction code M. Following the transaction, Blake’s reported holdings included 6,001 shares of Prenetics Global. The ownership record also listed 18,003 derivative securities. The filing reported these holdings separately as shares and derivative securities. Blake is identified as a director of Prenetics Global Ltd.
FAQs
Q: How many Prenetics Global shares did Leogrande Hudson Blake exercise?
A: Leogrande Hudson Blake exercised options covering 2,000 Prenetics Global shares on 4 September 2026. The filing reported an exercise price of $0 per share and identified the transaction with SEC code M.
Q: What were Blake’s Prenetics Global holdings after the transaction?
A: Following the option exercise, the filing reported that Blake owned 6,001 Prenetics Global shares. It also reported that Blake owned 18,003 Prenetics Global derivative securities.
Q: When did the Prenetics Global director option exercise occur?
A: The option exercise by Prenetics Global director Leogrande Hudson Blake occurred on 4 September 2026. The filing recorded the transaction under SEC transaction code M.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.